Resistance to diabetes-promoting lifestyle factors - What is the mechanism?

Diabetes Research and Clinical Practice

Volumn 97, Issue 2, 2012, Pages 172-174

  Kolb, Hubert ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT;

CELL PROTECTION; CELL STRESS; CELL SURVIVAL; DIABETOGENESIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE RESISTANCE; ENDOPLASMIC RETICULUM STRESS; EXERCISE; HORMESIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; METABOLIC STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; OXIDATIVE STRESS; PROTECTION; PROTEIN UNFOLDING;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HORMESIS; HUMANS; IMMUNITY, INNATE; LIFE STYLE; MALE; OBESITY; RISK FACTORS; STRESS, PHYSIOLOGICAL;

EID: 84865085172     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.06.006     Document Type: Note

References (20)

1. Kolb H., Mandrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia 2010, 53:10-20.
2. Blüher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010, 21:38-43.
3. Kolb H., Eizirik D.L. Resistance to type 2 diabetes mellitus: a matter of hormesis?. Nat Rev Endocrinol 2011, 8:183-192.
4. Caesar R., Fak F., Backhed F. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med 2010, 268:320-328.
5. Medvedev A.E., Sabroe I., Hasday J.D., Vogel S.N. Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J Endotoxin Res 2006, 12:133-150.
6. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067-2072.
7. Gonzalez F., Rote N.S., Minium J., O'leary V.B., Kirwan J.P. Obese reproductive-age women exhibit a proatherogenic inflammatory response during hyperglycemia. Obesity (Silver Spring) 2007, 15:2436-2444.
8. Jialal I., Huet B.A., Kaur H., Chien A., Devaraj S. Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care 2012, 35:900-904.
9. Ristow M., Zarse K., Oberbach A., Klöting N., Birringer M., Kiehntopf M., et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U S A 2009, 106:8665-8670.
10. Strobel N.A., Peake J.M., Matsumoto A., Marsh S.A., Coombes J.S., Wadley G.D. Antioxidant supplementation reduces skeletal muscle mitochondrial biogenesis. Med Sci Sports Exerc 2010.
11. Olsen D.B., Scheede-Bergdahl C., Reving D., Boushel R., Dela F. The effect of rowing on endothelial function and insulin action in healthy controls and in patients with type 2 diabetes. Scand J Med Sci Sports 2011, 21:420-430.
12. Meex R.C., Schrauwen-Hinderling V.B., Moonen-Kornips E., Schaart G., Mensink M., Phielix E., et al. Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity. Diabetes 2010, 59:572-579.
13. Hotamisligil G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010, 140:900-917.
14. Eizirik D.L., Cardozo A.K., Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 2008, 29:42-61.
15. Latreille M., Laberge M.K., Bourret G., Yamani L., Larose L. Deletion of Nck1 attenuates hepatic ER stress signaling, improves glucose tolerance and insulin signaling in liver of obese mice. Am J Physiol Endocrinol Metab 2010.
16. Bellmann K., Hui L., Radons J., Burkart V., Kolb H. Low stress response enhances vulnerability of islet cells in diabetes-prone BB rats. Diabetes 1997, 46:232-236.
17. Pirot P., Eizirik D.L., Cardozo A.K. Interferon-gamma potentiates endoplasmic reticulum stress-induced death by reducing pancreatic beta cell defence mechanisms. Diabetologia 2006, 49:1229-1236.
18. Boettler U., Sommerfeld K., Volz N., Pahlke G., Teller N., Somoza V., et al. Coffee constituents as modulators of Nrf2 nuclear translocation and ARE (EpRE)-dependent gene expression. J Nutr Biochem 2011, 22:426-440.
19. Kempf K., Herder C., Erlund I., Kolb H., Martin S., Carstensen M., et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr 2010, 91:950-957.
20. Wedick N.M., Brennan A.M., Sun Q., Hu F.B., Mantzoros C.S., van Dam R.M. Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial. Nutr J 2011, 10:93.